0 Comments
0 Shares
106 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Molecular Building Blocks: How Modified Nucleotides Are Powering mRNA TherapeuticsThe Pseudouridine Market is experiencing robust growth as modified nucleotides continue to power mRNA therapeutics and vaccine development. According to market reports, the global Pseudouridine Market was valued at USD 500 million in 2024 and is projected to reach USD 1.5 billion by 2035, exhibiting a CAGR of 10.6% during the forecast period. This impressive growth reflects the...0 Comments 0 Shares 337 Views 0 Reviews
-
Next-Generation Solutions in the mRNA Cancer Vaccines and Therapeutics MarketThe burgeoning mRNA Cancer Vaccines and Therapeutics Market is witnessing exponential growth, with volume estimates projecting an increase from USD 6.25 million in 2024 to an impressive USD 39.01 million by 2035. This growth equates to a remarkable compound annual growth rate (CAGR) of 18.12%, indicative of a significant shift in how cancer is treated. The emergence of mRNA technology...0 Comments 0 Shares 453 Views 0 Reviews
-
Synthetic mRNA Therapeutics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033" According to the latest report published by Data Bridge Market Research, the Synthetic mRNA Therapeutics Market The global synthetic mRNA therapeutics market size was valued at USD 2.86 billion in 2025 and is expected to reach USD 11.73 billion by 2033, at a CAGR of 19.30% during the forecast period The universal Synthetic mRNA Therapeutics...0 Comments 0 Shares 545 Views 0 Reviews
-
Oligonucleotide Therapeutics Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Oligonucleotide Therapeutics Market CAGR Value As per Data Bridge Market Research Analysis the global oligonucleotide therapeutics market size was valued at USD 30.56 billion in 2025 and is expected to reach USD 86.26 billion by 2033, at a CAGR of 13.85% during the forecast period The...0 Comments 0 Shares 18 Views 0 Reviews